PHASE 3 STUDY INVESTIGATES SLE TX.
| Publicado en: | Dermatology Times Vol. 39; no. 5; p. 14 |
|---|---|
| Formato: | brief item Journal Article |
| Publicado: |
MJH Life Sciences
May2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129524631&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 129524631 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01966197 DTI jtl: Dermatology Times issn: 01966197 maglogo: N pubinfo: dt: May2018 vid: 39 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 129524631 129524631 129524631 129524631 ppf: 14 ppct: 0 formats: tig: atl: PHASE 3 STUDY INVESTIGATES SLE TX. aug: sug: subj: Belimumab Therapeutic Use Rituximab Therapeutic Use Lupus Erythematosus, Systemic Drug Therapy Drug Combinations pubtype: Trade Publication doctype: brief item Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|